Yahoo Web Search

Search results

    • Ipsen drug for rare liver disease approved by FDA

      Ipsen drug for rare liver disease approved by FDA

      BioPharma Dive via Yahoo Finance· 4 days ago

      The medicine will join Intercept’s Ocaliva as a treatment option for primary biliary cholangitis. Another drug, from the now Gilead-owned CymaBay, could...

    • Opinion | If Not in New York, Then Where?

      Opinion | If Not in New York, Then Where?

      New York Times· 3 days ago

      Here is what the indefinite pause on New York City’s congestion pricing program, if it sticks, will cost: 120,000 more cars daily clogging Lower...